Accure is the 1stlaser to offer FDA approved acne curing not just management via:
Selective absorption on sebum glands by the novel 1726 nm wavelength
Average clearance of 80% after completing the sessions
Automated end-point to ensure consistent success in shrinking deep & enlarged sebum glands
No systemic side-effects, almost no downtime, suitable for all skin colors
Treatments:
Acne Monotherapy
1726 nm
Why choose Accure?
FDA mild-to-severe approved
Accure is the 1stacne monotherapy with automatic end-point detection to be approved by FDA for treatingmild to severeacne
Sebum Selectivity
Accure's 1726 nm novel wavelength selectively target sebum and heat it which consecutively leads to denaturation & shrinking of enlarged sebum glands without burning it
Up tp 90% Clearance
Accure clears 75-90% in 3-4 sessions. Accure results lasts long without relapse which guarantees a high patient satisfaction rate
Endpoint = Efficacy
Accure is the only acne laser with machine learning to automatically detect the effective end-point. It monitors skin & sebum temperature 3600 times per minute to reach optimal efficacy...not more & not less
Optimal Safety
Accure offers machine learning technology via automating pulse tracking & temperature monitoring. It cuts-off any surplus energy to provide you with the highest available safety margin
Long-lasting results
Durability of results is key in acne. Unlike systemic & topical treatment options, Accure results proved to last for a long time & some cases showed no recurrence after 3 years
Easy Compliance
Accure is done once a month for 3-4 sessions. No patient compliance issues, no systemic side effects, and it is suitable for all skin types
Built-in Comfort
Accure includes built-in air cooling & boosting mode (gradual energy increase) to maximize patient comfort. Statistics showed it is easily tolerable with just topical anesthesia & pain score was only 4/10
